| Bindu S Bamrah, MD | |
|
3077 N Mayfair Rd Ste 305, Wauwatosa, WI 53222-4305 | |
| (414) 384-6700 | |
| Not Available |
| Full Name | Bindu S Bamrah |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 28 Years |
| Location | 3077 N Mayfair Rd Ste 305, Wauwatosa, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285602482 | NPI | - | NPPES |
| 34168100 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XX0005X | Orthopaedic Surgery - Sports Medicine | 39006 (Wisconsin) | Secondary |
| 207X00000X | Orthopaedic Surgery | 39006 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension All Saints Hospital | Racine, WI | Hospital |
| Midwest Orthopedic Specialty Hospital | Franklin, WI | Hospital |
| Ascension Se Wisconsin Hospital - St Joseph Campus | Milwaukee, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthopedic Surgeons Of Wisconsin Sc | 5294727152 | 41 |
| Wheaton Franciscan Medical Group Inc | 8628980943 | 594 |
News Archive
MicroStockProfit.com announces an investment report featuring Osiris Therapeutics Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
In a dramatic rewrite of the recipe for life, scientists from Florida today described the design of a new type of DNA with 12 chemical letters instead of the usual four.
Mount Sinai has partnered with Theragene Pharmaceuticals, Inc. to advance a novel airway-delivered gene therapy for treating pulmonary hypertension (PH), a form of high blood pressure in blood vessels in the lungs that is linked to heart failure.
University of Virginia researchers have developed a revolutionary three-dimensional model that allows them to visualize how breast tissue grows in its earliest stages, giving them the closest look ever at the very beginnings of breast cancer.
Ovatech, an emerging women's health-focused company, announced today that the Company's Phase 2 clinical study of its non-hormonal, intravaginal contraceptive ring, Ovaprene, has been successfully completed. Ovaprene is a 'one-size-fits-all' patented, female-controlled, intravaginal organic silicone ring barrier-contraceptive that is designed to continuously release spermiostatic and spermicidal non-drug agents over a four-week period.
› Verified 2 days ago
| Entity Name | Ascension Medical Group-southeast Wisconsin Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609881077 PECOS PAC ID: 8628980943 Enrollment ID: O20031104000421 |
News Archive
MicroStockProfit.com announces an investment report featuring Osiris Therapeutics Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
In a dramatic rewrite of the recipe for life, scientists from Florida today described the design of a new type of DNA with 12 chemical letters instead of the usual four.
Mount Sinai has partnered with Theragene Pharmaceuticals, Inc. to advance a novel airway-delivered gene therapy for treating pulmonary hypertension (PH), a form of high blood pressure in blood vessels in the lungs that is linked to heart failure.
University of Virginia researchers have developed a revolutionary three-dimensional model that allows them to visualize how breast tissue grows in its earliest stages, giving them the closest look ever at the very beginnings of breast cancer.
Ovatech, an emerging women's health-focused company, announced today that the Company's Phase 2 clinical study of its non-hormonal, intravaginal contraceptive ring, Ovaprene, has been successfully completed. Ovaprene is a 'one-size-fits-all' patented, female-controlled, intravaginal organic silicone ring barrier-contraceptive that is designed to continuously release spermiostatic and spermicidal non-drug agents over a four-week period.
› Verified 2 days ago
| Entity Name | Orthopedic Surgeons Of Wisconsin Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295769321 PECOS PAC ID: 5294727152 Enrollment ID: O20040331001176 |
News Archive
MicroStockProfit.com announces an investment report featuring Osiris Therapeutics Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
In a dramatic rewrite of the recipe for life, scientists from Florida today described the design of a new type of DNA with 12 chemical letters instead of the usual four.
Mount Sinai has partnered with Theragene Pharmaceuticals, Inc. to advance a novel airway-delivered gene therapy for treating pulmonary hypertension (PH), a form of high blood pressure in blood vessels in the lungs that is linked to heart failure.
University of Virginia researchers have developed a revolutionary three-dimensional model that allows them to visualize how breast tissue grows in its earliest stages, giving them the closest look ever at the very beginnings of breast cancer.
Ovatech, an emerging women's health-focused company, announced today that the Company's Phase 2 clinical study of its non-hormonal, intravaginal contraceptive ring, Ovaprene, has been successfully completed. Ovaprene is a 'one-size-fits-all' patented, female-controlled, intravaginal organic silicone ring barrier-contraceptive that is designed to continuously release spermiostatic and spermicidal non-drug agents over a four-week period.
› Verified 2 days ago
| Entity Name | Midwest Orthopedic Specialty Hospital Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275127375 PECOS PAC ID: 7113078833 Enrollment ID: O20210317001381 |
News Archive
MicroStockProfit.com announces an investment report featuring Osiris Therapeutics Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
In a dramatic rewrite of the recipe for life, scientists from Florida today described the design of a new type of DNA with 12 chemical letters instead of the usual four.
Mount Sinai has partnered with Theragene Pharmaceuticals, Inc. to advance a novel airway-delivered gene therapy for treating pulmonary hypertension (PH), a form of high blood pressure in blood vessels in the lungs that is linked to heart failure.
University of Virginia researchers have developed a revolutionary three-dimensional model that allows them to visualize how breast tissue grows in its earliest stages, giving them the closest look ever at the very beginnings of breast cancer.
Ovatech, an emerging women's health-focused company, announced today that the Company's Phase 2 clinical study of its non-hormonal, intravaginal contraceptive ring, Ovaprene, has been successfully completed. Ovaprene is a 'one-size-fits-all' patented, female-controlled, intravaginal organic silicone ring barrier-contraceptive that is designed to continuously release spermiostatic and spermicidal non-drug agents over a four-week period.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bindu S Bamrah, MD 3077 N Mayfair Rd Ste 305, Wauwatosa, WI 53222-4305 Ph: (414) 384-6700 | Bindu S Bamrah, MD 3077 N Mayfair Rd Ste 305, Wauwatosa, WI 53222-4305 Ph: (414) 384-6700 |
News Archive
MicroStockProfit.com announces an investment report featuring Osiris Therapeutics Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
In a dramatic rewrite of the recipe for life, scientists from Florida today described the design of a new type of DNA with 12 chemical letters instead of the usual four.
Mount Sinai has partnered with Theragene Pharmaceuticals, Inc. to advance a novel airway-delivered gene therapy for treating pulmonary hypertension (PH), a form of high blood pressure in blood vessels in the lungs that is linked to heart failure.
University of Virginia researchers have developed a revolutionary three-dimensional model that allows them to visualize how breast tissue grows in its earliest stages, giving them the closest look ever at the very beginnings of breast cancer.
Ovatech, an emerging women's health-focused company, announced today that the Company's Phase 2 clinical study of its non-hormonal, intravaginal contraceptive ring, Ovaprene, has been successfully completed. Ovaprene is a 'one-size-fits-all' patented, female-controlled, intravaginal organic silicone ring barrier-contraceptive that is designed to continuously release spermiostatic and spermicidal non-drug agents over a four-week period.
› Verified 2 days ago
Thomas Joseph Parisi, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3077 N Mayfair Rd Ste 305, Wauwatosa, WI 53222 Phone: 414-384-6700 Fax: 414-727-1058 | |
James R Heaberlin, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2999 N Mayfair Rd, Wauwatosa, WI 53222 Phone: 414-479-7000 Fax: 414-479-7001 | |
Conor Patrick Mcbride, Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 8701 W Watertown Plank Rd, Wauwatosa, WI 53226 Phone: 414-456-8296 | |
Sean Carroll Tracy, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2500 N Mayfair Rd, Suite 500, Wauwatosa, WI 53226 Phone: 414-257-2525 Fax: 414-257-1772 | |
Brian A. Mccarty, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3077 N Mayfair Rd Ste 100, Wauwatosa, WI 53222 Phone: 414-384-6700 Fax: 414-727-1058 | |
David L Becker, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3289 N Mayfair Rd, Wauwatosa, WI 53222 Phone: 414-771-7900 Fax: 414-771-7249 |